Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery

With their seemingly limitless capacity for self-improvement, stem cells have a wide range of potential uses in the medical field. Stem-cell-secreted extracellular vesicles (EVs), as paracrine components of stem cells, are natural nanoscale particles that transport a variety of biological molecules and facilitate cell-to-cell communication which have been also widely used for targeted drug delivery. These nanocarriers exhibit inherent advantages, such as strong cell or tissue targeting and low immunogenicity, which synthetic nanocarriers lack. However, despite the tremendous therapeutic potential of stem cells and EVs, their further clinical application is still limited by low yield and a lack of standardized isolation and purification protocols. In recent years, inspired by the concept of biomimetics, a new approach to biomimetic nanocarriers for drug delivery has been developed through combining nanotechnology and bioengineering. This article reviews the application of biomimetic nanocarriers derived from stem cells and their EVs in targeted drug delivery and discusses their advantages and challenges in order to stimulate future research.

[1]  A. K. Mishra,et al.  Nanotechnology in combating biofilm: A smart and promising therapeutic strategy , 2023, Frontiers in Microbiology.

[2]  Zihui Gao,et al.  Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy. , 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  M. Ahmad,et al.  Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives , 2023, 3 Biotech.

[4]  Hangjun Xu,et al.  Microvesicles as drug delivery systems: A new frontier for bionic therapeutics in cancer , 2022, Journal of Drug Delivery Science and Technology.

[5]  Jianqing Gao,et al.  Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system , 2022, Drug Delivery and Translational Research.

[6]  Ronnie H. Fang,et al.  Targeting drugs to tumours using cell membrane-coated nanoparticles , 2022, Nature reviews. Clinical oncology.

[7]  Shixin Xu,et al.  Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain? , 2022, Stem Cell Reviews and Reports.

[8]  Junyong Wu,et al.  Apoptotic bodies for advanced drug delivery and therapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Michael R Hamblin,et al.  Stem cell membrane-coated abiotic nanomaterials for biomedical applications. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Weiyue Zhang,et al.  Stem cell membrane-camouflaged targeted delivery system in tumor , 2022, Materials today. Bio.

[11]  Xun Li,et al.  Mesenchymal stem cells-based therapy in liver diseases , 2022, Molecular Biomedicine.

[12]  M. Kamal,et al.  Natural therapeutics and nutraceuticals for lung diseases: Traditional significance, phytochemistry, and pharmacology. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  M. Taheri,et al.  Therapeutic Potential of Microvesicles in Cell Therapy and Regenerative Medicine of Ocular Diseases With an Especial Focus on Mesenchymal Stem Cells-Derived Microvesicles , 2022, Frontiers in Genetics.

[14]  Zihua Wang,et al.  Recent Advances in the Application of Mesenchymal Stem Cell-Derived Exosomes for Cardiovascular and Neurodegenerative Disease Therapies , 2022, Pharmaceutics.

[15]  A. Al-Hendy,et al.  Stem Cell Therapy: From Idea to Clinical Practice , 2022, International journal of molecular sciences.

[16]  Yuan Zhong,et al.  Cell membrane camouflaged biomimetic nanoparticles: Focusing on tumor theranostics , 2022, Materials today. Bio.

[17]  G. Camussi Exosomes and Microvesicles: from Stem Cell Biology to Translation in Human Diseases , 2022, Stem Cell Reviews and Reports.

[18]  C. Vicinanza,et al.  Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications , 2022, World journal of stem cells.

[19]  A. Conigliaro,et al.  Molecular Mediators of RNA Loading into Extracellular Vesicles , 2021, Cells.

[20]  A. Rizvanov,et al.  Application of Mesenchymal Stem Cells Derived Artificial Microvesicles for the Treatment of Canine Skin Wound , 2021, BioNanoScience.

[21]  Zhipeng Chen,et al.  Research Progress on Cell Membrane-Coated Biomimetic Delivery Systems , 2021, Frontiers in Bioengineering and Biotechnology.

[22]  Hongmei Liu,et al.  Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. , 2021, Colloids and surfaces. B, Biointerfaces.

[23]  E. Tasciotti,et al.  Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles , 2021, Nature Communications.

[24]  D. Offen,et al.  Intranasal delivery of mesenchymal stem cells‐derived extracellular vesicles for the treatment of neurological diseases , 2021, Stem cells.

[25]  A. Shetty,et al.  Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease , 2021, Aging and disease.

[26]  A. Goel,et al.  The therapeutic triad of extracellular vesicles: As drug targets, as drugs, and as drug carriers. , 2021, Biochemical pharmacology.

[27]  J. Ge,et al.  Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. , 2021, Biomaterials.

[28]  Jiyong Liu,et al.  Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles , 2021, Drug delivery.

[29]  Chunhong Li,et al.  Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy , 2021, Drug delivery.

[30]  Mayur M. Patel,et al.  Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers , 2021, Nano-micro letters.

[31]  C. Pollock,et al.  Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury , 2021, International journal of molecular sciences.

[32]  S. Chauhan,et al.  Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science , 2021, Journal of Drug Delivery Science and Technology.

[33]  Nimit Shah,et al.  Biomimetic Nanotechnology: A Natural Path Forward for Tumor-Selective and Tumor-Specific NIR Activable Photonanomedicines , 2021, Pharmaceutics.

[34]  J. Baulch,et al.  Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer’s disease , 2021, Alzheimer's Research & Therapy.

[35]  A. Bertoni,et al.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Carrying miRNA as a Potential Multi Target Therapy to COVID-19: an In Silico Analysis , 2021, Stem Cell Reviews and Reports.

[36]  S. Zheng,et al.  Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine , 2021, Frontiers in Pharmacology.

[37]  Nan Zhang,et al.  Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics , 2021, Clinical and translational medicine.

[38]  B. Joung,et al.  Co-delivery of curcumin and miRNA-144-3p using heart-targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Fei Liu,et al.  Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer , 2021, Stem cell research & therapy.

[40]  T. Webster,et al.  Recent advances in mesenchymal stem cell membrane-coated nanoparticles for enhanced drug delivery. , 2020, Biomaterials science.

[41]  T. Iwasaki,et al.  Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy , 2020, Science Translational Medicine.

[42]  S. Pacelli,et al.  Investigation of human adipose stem cell-derived nanoparticles as a biomimetic carrier for intracellular drug delivery. , 2020, Nanoscale.

[43]  R. Jafari,et al.  Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine , 2020, Journal of translational medicine.

[44]  S. Schwartz,et al.  Extracellular Vesicles as Drug Delivery Systems in Cancer , 2020, Pharmaceutics.

[45]  S. Schwartz,et al.  The potential of nanomedicine to alter cancer stem cell dynamics: the impact of extracellular vesicles. , 2020, Nanomedicine.

[46]  M. Vallet‐Regí,et al.  Nanoparticles Coated with Cell Membranes for Biomedical Applications , 2020, Biology.

[47]  M. Nishikawa,et al.  Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[48]  R. Shi,et al.  Mesenchymal stem cell-derived exosomes: Hope for spinal cord injury repair. , 2020, Stem cells and development.

[49]  Wuli Yang,et al.  Highly biosafe biomimetic stem cell membrane-disguised nanovehicles for cartilage regeneration. , 2020, Journal of materials chemistry. B.

[50]  Wei Huang,et al.  Recent advances in drug delivery systems for targeting cancer stem cells , 2020, Acta pharmaceutica Sinica. B.

[51]  S. Yamanaka Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges. , 2020, Cell stem cell.

[52]  S. Mohsin,et al.  Role of Stem Cell Derived Microvesicles in Cardiovascular Disease. , 2020, Journal of cardiovascular pharmacology.

[53]  H. Barrera-Saldana,et al.  Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review. , 2020, Archives of medical research.

[54]  A. Piras,et al.  Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[55]  T. K. Phan,et al.  Unleashing the therapeutic potential of apoptotic bodies , 2020, Biochemical Society transactions.

[56]  C. Tirolo,et al.  Extracellular Vesicles as Nanotherapeutics for Parkinson’s Disease , 2020, Biomolecules.

[57]  D. Offen,et al.  Promising Opportunities for Treating Neurodegenerative Diseases with Mesenchymal Stem Cell-Derived Exosomes , 2020, Biomolecules.

[58]  Yueqiu Chen,et al.  HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis , 2020, Stem Cell Research & Therapy.

[59]  Xuexi Wang,et al.  Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine , 2020, World journal of stem cells.

[60]  A. E. Elçin,et al.  Therapeutic Applications of Stem Cells and Extracellular Vesicles in Emergency Care: Futuristic Perspectives , 2020, Stem Cell Reviews and Reports.

[61]  Jun Yang,et al.  Exosome: a significant nano-scale drug delivery carrier. , 2020, Journal of materials chemistry. B.

[62]  Bin Wang,et al.  Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy , 2020, Theranostics.

[63]  U. Galderisi,et al.  Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?☆ , 2020, Journal of Controlled Release.

[64]  Cuifeng Wang,et al.  Proinflammatory macrophage-derived microvesicles exhibit tumor tropism dependent on CCL2/CCR2 signaling axis and promote drug delivery via SNARE-mediated membrane fusion , 2020, Theranostics.

[65]  G. Camussi,et al.  Nephroprotective Potential of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Murine Model of Chronic Cyclosporine Nephrotoxicity , 2020, Frontiers in Cell and Developmental Biology.

[66]  D. Torella,et al.  Unravelling the Biology of Adult Cardiac Stem Cell-Derived Exosomes to Foster Endogenous Cardiac Regeneration and Repair , 2020, International journal of molecular sciences.

[67]  B. Ahn,et al.  Extracellular Vesicle- and Extracellular Vesicle Mimetics-Based Drug Delivery Systems: New Perspectives, Challenges, and Clinical Developments , 2020, Pharmaceutics.

[68]  R. Schiffelers,et al.  Extracellular vesicles as drug delivery systems: Why and how? , 2020, Advanced drug delivery reviews.

[69]  Xiuying Wang,et al.  Chitosan modified Fe3O4/KGN self-assembled nanoprobes for osteochondral MR diagnose and regeneration , 2020, Theranostics.

[70]  L. Suggs,et al.  Modulating inflammatory macrophages with an apoptotic body-inspired nanoparticle. , 2020, Acta biomaterialia.

[71]  C. Balistreri,et al.  Stem cell therapy: old challenges and new solutions , 2020, Molecular Biology Reports.

[72]  G. Faggian,et al.  Exosomes: From Potential Culprits to New Therapeutic Promise in the Setting of Cardiac Fibrosis , 2020, Cells.

[73]  Jinli Wang,et al.  MiR-101a loaded Extracellular Nanovesicles as Bioactive Carriers for Cardiac Repair , 2020, bioRxiv.

[74]  Chao Wang,et al.  Cell membrane-coated nanoparticles: research advances. , 2020, Nanomedicine.

[75]  D. He,et al.  Cell Membrane-camouflaged Nanoparticles as Drug Carriers for Cancer Therapy. , 2020, Acta biomaterialia.

[76]  Zhiwei Sun,et al.  Personalized detection of circling exosomal PD-L1 based on Fe3O4@TiO2 isolation and SERS immunoassay. , 2020, Biosensors & bioelectronics.

[77]  Lesley Cheng,et al.  Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles. , 2020, Methods.

[78]  Ling Li,et al.  Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source , 2020, Drug delivery.

[79]  E. Falcieri,et al.  Apoptotic Bodies: Particular Extracellular Vesicles Involved in Intercellular Communication , 2020, Biology.

[80]  M. Alcaraz,et al.  Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases , 2019, Cells.

[81]  J. Xu,et al.  Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer. , 2019, Nanomedicine : nanotechnology, biology, and medicine.

[82]  Jenna A. Dombroski,et al.  Engineering of Exosomes to Target Cancer Metastasis , 2019, Cellular and Molecular Bioengineering.

[83]  J. Devoisselle,et al.  Post-production modifications of murine mesenchymal stem cell (mMSC) derived extracellular vesicles (EVs) and impact on their cellular interaction. , 2019, Biomaterials.

[84]  E. Tasciotti,et al.  Exosome-like nanovectors for drug delivery in cancer. , 2019, Current medicinal chemistry.

[85]  Jee‐Heon Jeong,et al.  Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives. , 2019, European journal of cell biology.

[86]  U. Armato,et al.  Mesenchymal stromal cells-exosomes: a promising cell-free therapeutic tool for wound healing and cutaneous regeneration , 2019, Burns & Trauma.

[87]  J. Colacino,et al.  Environmental exposures, stem cells, and cancer. , 2019, Pharmacology & therapeutics.

[88]  Y. Gho,et al.  Embryonic stem cell-derived extracellular vesicle-mimetic nanovesicles rescue erectile function by enhancing penile neurovascular regeneration in the streptozotocin-induced diabetic mouse , 2019, Scientific Reports.

[89]  J. Whitelegge,et al.  Extracellular Vesicles From Auditory Cells as Nanocarriers for Anti-inflammatory Drugs and Pro-resolving Mediators , 2019, Front. Cell. Neurosci..

[90]  A. Fernandez-Gonzalez,et al.  Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. , 2019, JCI insight.

[91]  J. Simpson,et al.  The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles. , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[92]  Yanbo Zhang,et al.  Mesenchymal Stem Cells for Regenerative Medicine , 2019, Cells.

[93]  G. Pastorin,et al.  Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers , 2019, International journal of molecular sciences.

[94]  Thierry Burnouf,et al.  Extracellular Microvesicles as New Industrial Therapeutic Frontiers. , 2019, Trends in biotechnology.

[95]  Xiaobing Fu,et al.  Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases , 2019, Stem Cell Research & Therapy.

[96]  Methichit Wattanapanitch Recent Updates on Induced Pluripotent Stem Cells in Hematological Disorders , 2019, Stem cells international.

[97]  Roger M. Ilagan,et al.  Mesenchymal stromal cell-derived exosomes improve mitochondrial health in pulmonary arterial hypertension. , 2019, American journal of physiology. Lung cellular and molecular physiology.

[98]  A. Hill,et al.  Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications , 2019, Journal of extracellular vesicles.

[99]  Haiyang Hu,et al.  Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges. , 2019, Journal of materials chemistry. B.

[100]  Xuan Sun,et al.  Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization , 2019, Cardiovascular research.

[101]  Xin Niu,et al.  Embryonic Stem Cells‐Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy , 2019, Advanced science.

[102]  Yoshimi Yashiro,et al.  Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. , 2019, Physiological reviews.

[103]  Y. Tabata,et al.  Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[104]  S. Antimisiaris,et al.  Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery , 2018, Pharmaceutics.

[105]  Wei Wang,et al.  Recent advancements in the use of exosomes as drug delivery systems , 2018, Journal of Nanobiotechnology.

[106]  L. Ramenghi,et al.  Microvesicles as promising biological tools for diagnosis and therapy , 2018, Expert review of proteomics.

[107]  L. Gentile,et al.  A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres. , 2018, Stem Cell Research.

[108]  Shunliang Xu,et al.  Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer’s Disease , 2018, Neurochemical Research.

[109]  S. Jeong,et al.  A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy , 2018, Front. Pharmacol..

[110]  Xuan Sun,et al.  Intravenous mesenchymal stem cell-derived exosomes ameliorate myocardial inflammation in the dilated cardiomyopathy. , 2018, Biochemical and biophysical research communications.

[111]  S. Shi,et al.  Circulating apoptotic bodies maintain mesenchymal stem cell homeostasis and ameliorate osteopenia via transferring multiple cellular factors , 2018, Cell Research.

[112]  David Tareste,et al.  Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems. , 2018, ACS nano.

[113]  Hua Han,et al.  Stem cells: a promising candidate to treat neurological disorders , 2018, Neural regeneration research.

[114]  M. Y. Thanuja,et al.  Bioengineered cellular and cell membrane‐derived vehicles for actively targeted drug delivery: So near and yet so far , 2018, Advanced drug delivery reviews.

[115]  Liang Xie,et al.  Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application , 2018, Stem cells international.

[116]  Ronnie H. Fang,et al.  Cell Membrane Coating Nanotechnology , 2018, Advanced materials.

[117]  Xiujie Wang,et al.  Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium , 2018, Journal of cellular and molecular medicine.

[118]  Jianping Zhou,et al.  Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy. , 2018, Biomaterials science.

[119]  Ronghu Wu,et al.  Extracellular vesicles from bone marrow-derived mesenchymal stromal cells support ex vivo survival of human antibody secreting cells , 2018, Journal of extracellular vesicles.

[120]  M. Ghahremani,et al.  Mesenchymal stem cell-derived extracellular vesicles: novel frontiers in regenerative medicine , 2018, Stem Cell Research & Therapy.

[121]  Hong Tang,et al.  Stem Cells Transplantation in the Treatment of Patients with Liver Failure. , 2018, Current stem cell research & therapy.

[122]  Junhua Wu,et al.  Exosome-Mimetic Nanovesicles from Hepatocytes promote hepatocyte proliferation in vitro and liver regeneration in vivo , 2018, Scientific Reports.

[123]  Hakho Lee,et al.  New Technologies for Analysis of Extracellular Vesicles. , 2018, Chemical reviews.

[124]  T. Meulia,et al.  Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model , 2018, Stem Cell Research & Therapy.

[125]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[126]  Carmen Pazos,et al.  Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes , 2018, Journal of extracellular vesicles.

[127]  M. Stojkovic,et al.  Ethical and Safety Issues of Stem Cell-Based Therapy , 2018, International journal of medical sciences.

[128]  Robert J. Vincent,et al.  Induced Pluripotent Stem Cell (iPSC)–Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair Than iPSCs , 2017, Circulation research.

[129]  S. Bicciato,et al.  Regeneration of the entire human epidermis using transgenic stem cells , 2017, Nature.

[130]  L. V. Van Laake,et al.  Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology , 2017, Cardiovascular research.

[131]  J. Sánchez-Alcázar,et al.  Dynamic Reorganization of the Cytoskeleton during Apoptosis: The Two Coffins Hypothesis , 2017, International journal of molecular sciences.

[132]  S. Kourembanas,et al.  Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency , 2017, Front. Cardiovasc. Med..

[133]  J. Wojtkiewicz,et al.  The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds) , 2017, Stem cells international.

[134]  Nupur Basu,et al.  Hyaluronic acid coatings as a simple and efficient approach to improve MSC homing toward the site of inflammation , 2017, Scientific Reports.

[135]  Joseph C. Wu,et al.  Comparison of Non‐Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell‐ versus Induced Pluripotent Stem Cell‐Derived Cardiomyocytes , 2017, Stem cells.

[136]  Oh Youn Kim,et al.  Extracellular vesicle mimetics: Novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines. , 2017, Seminars in cell & developmental biology.

[137]  T. Kanjevac,et al.  Nanoparticles in Antiviral Therapy , 2017, Antimicrobial Nanoarchitectonics.

[138]  Lanjuan Li,et al.  Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure , 2017, Stem Cell Research & Therapy.

[139]  Mario Gimona,et al.  Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use , 2017, International journal of molecular sciences.

[140]  Yanning Liu,et al.  MiR‐122 modification enhances the therapeutic efficacy of adipose tissue‐derived mesenchymal stem cells against liver fibrosis , 2017, Journal of cellular and molecular medicine.

[141]  Gang Liu,et al.  Nanobiotechnology: Cell Membrane-Based Delivery Systems. , 2017, Nano today.

[142]  N. Khanlarkhani,et al.  Multipotent Stem Cell and Current Application. , 2017, Acta medica Iranica.

[143]  Hongguang Zhang,et al.  hucMSC Exosome-Derived GPX1 Is Required for the Recovery of Hepatic Oxidant Injury. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[144]  G. Angelini,et al.  Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[145]  R. Califf,et al.  Clarifying Stem-Cell Therapy's Benefits and Risks. , 2016, The New England journal of medicine.

[146]  A. Lendlein,et al.  Nanocarriers for drug delivery into and through the skin - Do existing technologies match clinical challenges? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[147]  Pieter Vader,et al.  Extracellular vesicles for drug delivery. , 2016, Advanced drug delivery reviews.

[148]  H. T. Park,et al.  RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer. , 2016, Biomaterials.

[149]  J. Seghatchian,et al.  Update on extracellular vesicles inside red blood cell storage units: Adjust the sails closer to the new wind. , 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[150]  R. Mahla Stem Cells Applications in Regenerative Medicine and Disease Therapeutics , 2016, International journal of cell biology.

[151]  U. Galderisi,et al.  Clinical Trials with Mesenchymal Stem Cells: An Update , 2016, Cell transplantation.

[152]  Juliane Nguyen,et al.  Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[153]  R. Schiffelers,et al.  PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[154]  F. Wendler,et al.  Extracellular vesicles round off communication in the nervous system , 2016, Nature Reviews Neuroscience.

[155]  S. Mayor,et al.  GPI-anchored protein organization and dynamics at the cell surface , 2016, Journal of Lipid Research.

[156]  S. Redenti,et al.  Characterization of Induced Pluripotent Stem Cell Microvesicle Genesis, Morphology and Pluripotent Content , 2016, Scientific Reports.

[157]  Roberto Mayor,et al.  The front and rear of collective cell migration , 2016, Nature Reviews Molecular Cell Biology.

[158]  A. Hill,et al.  Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey , 2016, Journal of extracellular vesicles.

[159]  Sahil D. Shah,et al.  Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. , 2015, Methods.

[160]  Mohsin Khan,et al.  Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. , 2015, Circulation research.

[161]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[162]  Kelly Aubertin,et al.  Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[163]  C. Emiliani,et al.  Exosome-based strategies for Diagnosis and Therapy. , 2015, Recent patents on CNS drug discovery.

[164]  A. Lloyd,et al.  Nanoprecipitation of polymeric nanoparticle micelles based on 2-methacryloyloxyethyl phosphorylcholine (MPC) with 2-(diisopropylamino)ethyl methacrylate (DPA), for intracellular delivery applications , 2015, Journal of Materials Science: Materials in Medicine.

[165]  Cecilia Lässer Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle , 2015, Expert opinion on biological therapy.

[166]  Imre Mäger,et al.  Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.

[167]  Andrew F. Hill,et al.  Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.

[168]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[169]  A. Bahrami,et al.  Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy , 2015, Cell biology international.

[170]  Eoin P. McNeill,et al.  MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs , 2014, Proceedings of the National Academy of Sciences.

[171]  Jamie R. Lead,et al.  Quantitative measurement of the nanoparticle size and number concentration from liquid suspensions by atomic force microscopy. , 2014, Environmental science. Processes & impacts.

[172]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[173]  N. Tyagi,et al.  Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics , 2014, Molecular Neurobiology.

[174]  A. Tedgui,et al.  Microvesicles as Cell–Cell Messengers in Cardiovascular Diseases , 2014, Circulation research.

[175]  Andrew F. Hill,et al.  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles , 2014, Journal of extracellular vesicles.

[176]  R. Nieuwland,et al.  Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.

[177]  M. Chopp,et al.  Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[178]  Seok-Goo Cho,et al.  Clinical applications of mesenchymal stem cells , 2013, The Korean journal of internal medicine.

[179]  J. Leonard,et al.  FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver , 2013, Pharmaceuticals.

[180]  S. Lim,et al.  Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. , 2013, Advanced drug delivery reviews.

[181]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[182]  Yu Xin Wang,et al.  The emerging biology of muscle stem cells: Implications for cell-based therapies , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[183]  W. Stoorvogel,et al.  Identification of Distinct Populations of Prostasomes That Differentially Express Prostate Stem Cell Antigen, Annexin A1, and GLIPR2 in Humans1 , 2012, Biology of reproduction.

[184]  D. Hwang,et al.  Proteomic analysis of microvesicles derived from human mesenchymal stem cells. , 2012, Journal of proteome research.

[185]  Dongmei Sun,et al.  Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[186]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[187]  Manuel T. Silva Secondary necrosis: The natural outcome of the complete apoptotic program , 2010, FEBS letters.

[188]  Luigi Biancone,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[189]  M. Zöller,et al.  CD44v6 dependence of premetastatic niche preparation by exosomes. , 2009, Neoplasia.

[190]  Carolyn R Bertozzi,et al.  Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. , 2009, Angewandte Chemie.

[191]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[192]  V. Nurcombe,et al.  Wnt signaling controls the fate of mesenchymal stem cells. , 2009, Gene.

[193]  Jacopo Meldolesi,et al.  Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.

[194]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[195]  R. Young,et al.  Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.

[196]  S. Elmore Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[197]  M. Record,et al.  Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. , 2007, Biochimie.

[198]  O. Lindvall,et al.  Stem cells for the treatment of neurological disorders , 2006, Nature.

[199]  S. Perez,et al.  Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.

[200]  Anna Janowska-Wieczorek,et al.  Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.

[201]  Aled Clayton,et al.  Antigen‐presenting cell exosomes are protected from complement‐mediated lysis by expression of CD55 and CD59 , 2003, European journal of immunology.

[202]  J. Le Pecq,et al.  Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.

[203]  Y. Lo,et al.  Stability of endogenous and added RNA in blood specimens, serum, and plasma. , 2002, Clinical chemistry.

[204]  Y. Ueno,et al.  The process of ultrastructural changes from nuclei to apoptotic body , 1998, Virchows Archiv.

[205]  Jiacan Su,et al.  Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy , 2022, Extracellular Vesicles and Circulating Nucleic Acids.

[206]  Gong Cheng,et al.  Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery. , 2018, Cancer research.

[207]  Lily Yang,et al.  Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. , 2018, Biomaterials.

[208]  R. Menon,et al.  Placental Exosomes During Gestation: Liquid Biopsies Carrying Signals for the Regulation of Human Parturition. , 2018, Current pharmaceutical design.

[209]  Xiaohong Wang,et al.  Pathologic function and therapeutic potential of exosomes in cardiovascular disease. , 2015, Biochimica et biophysica acta.

[210]  Mahendra S Rao,et al.  A review of the methods for human iPSC derivation. , 2013, Methods in molecular biology.

[211]  J. P. Lopes,et al.  [Mesenchymal stem cell therapy in heart disease]. , 2013, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[212]  Gupta Manish,et al.  Targeted drug delivery system: A Review , 2011 .

[213]  C. Fong,et al.  Human Embryonic Stem Cells: Their Nature, Properties, and Uses , 2009 .